To become a leading global pharmaceutical company recognized for our specialty generics and innovative product portfolio, expanding across regulated markets and continuously moving up the pharmaceutical value chain under the banner of ‘Wellness Beyond Boundaries.
To deliver high quality, affordable pharmaceutical formulations to global markets, leveraging our EU GMP, UK MHRA and TGA Australia accredited facility, while maintaining cost leadership, regulatory excellence, and a deep commitment to patient wellbeing.